Oraya Therapeutics is a privately held, development-stage medical technology company, pioneering noninvasive radiation treatments for inflammatory and neovascular diseases of the eye. The company is currently testing its first application of the IRay® stereotactic radiotherapy system.
Location: United States, California, Newark
Member count: 51-200
Total raised: $42M
Founded date: 2007
Investors 1
| Date | Name | Website |
| 14.05.2021 | EW Healthc... | ewhealthca... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 20.07.2009 | - | $42M | - | venturebea... |
Mentions in press and media 6
| Date | Title | Description | Category | Author | Source |
| 04.11.2013 | Healthcare... | Anti-VEGF therapy proved to be... | - | - | medcitynew... |
| 20.07.2009 | Oraya scor... | Oraya Therapeutics, maker of r... | - | - | venturebea... |
| 11.01.2008 | Secretive ... | See our story on this Menlo Pa... | - | - | venturebea... |
| 11.01.2008 | Secretive ... | Oraya, a secretive Menlo Park,... | - | - | venturebea... |
| 18.06.2007 | Secretive ... | A tiny and stealthy medical-de... | - | - | venturebea... |
| - | Healthcare... | Oraya Therapeutics, one of Cal... | - | - | medcitynew... |